ÂÜÀòÂÒÂ×

Dr. Bruce A. Sherf joined The Company in 2008 as the Chief Technology Officer. Dr. Sherf, who has worked in the biotechnology industry since 1994, has particular expertise in cell-based reporter assay design and optimization, product development, and high-throughput screening applications for drug discovery. As CTO, he oversees INDIGO Biosciences’ product development, manufacturing, and technology transfer initiatives, as well as directing all Contract Services-related activities.